The emerging roles of bacterial proteases in intestinal diseases

A Caminero, M Guzman, J Libertucci, AE Lomax - Gut Microbes, 2023 - Taylor & Francis
Proteases are an evolutionarily conserved family of enzymes that degrade peptide bonds
and have been implicated in several common gastrointestinal (GI) diseases. Although …

Protease inhibition as new therapeutic strategy for GI diseases

N Vergnolle - Gut, 2016 - gut.bmj.com
The GI tract is the most exposed organ to proteases, both in physiological and
pathophysiological conditions. For digestive purposes, the lumen of the upper GI tract …

Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis

HJ Galipeau, A Caminero, W Turpin, M Bermudez-Brito… - Gastroenterology, 2021 - Elsevier
Background & Aims Altered gut microbiota composition and function have been associated
with inflammatory bowel diseases, including ulcerative colitis (UC), but the causality and …

[HTML][HTML] Antimicrobial peptides and the gut microbiome in inflammatory bowel disease

J Gubatan, DR Holman, CJ Puntasecca… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Antimicrobial peptides (AMP) are highly diverse and dynamic molecules that are expressed
by specific intestinal epithelial cells, Paneth cells, as well as immune cells in the …

The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response

R Martín, C Chamignon, N Mhedbi-Hajri, F Chain… - Scientific reports, 2019 - nature.com
The gut barrier plays an important role in human health. When barrier function is impaired,
altered permeability and barrier dysfunction can occur, leading to inflammatory bowel …

Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis

JP Motta, LG Bermúdez-Humarán, C Deraison… - Science translational …, 2012 - science.org
Elafin, a natural protease inhibitor expressed in healthy intestinal mucosa, has pleiotropic
anti-inflammatory properties in vitro and in animal models. We found that mucosal …

Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection

T Gobbetti, J Dalli, RA Colas… - Proceedings of the …, 2017 - National Acad Sciences
The resolution of inflammation is an active process orchestrated by specialized proresolving
lipid mediators (SPM) that limit the host response within the affected tissue; failure of …

[HTML][HTML] Regulation of intestinal permeability: the role of proteases

H Van Spaendonk, H Ceuleers, L Witters… - World journal of …, 2017 - ncbi.nlm.nih.gov
The gastrointestinal barrier is-with approximately 400 m 2-the human body's largest surface
separating the external environment from the internal milieu. This barrier serves a dual …

Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets

A dos Santos Ramos, GCS Viana… - Pharmacological …, 2021 - Elsevier
Crohn's disease (CD) and ulcerative colitis (UC) are the two main forms of inflammatory
bowel disease (IBD). Among the various immune cells involved in IBD, neutrophils are the …

Engineering lactococci and lactobacilli for human health

LG Bermúdez-Humarán, C Aubry, JP Motta… - Current opinion in …, 2013 - Elsevier
Highlights•Recombinant lactococci and lactobacilli have been successfully used in the last
years as safe mucosal delivery vectors for molecules of health interest.•The delivery of …